Curative Biotechnology Inc (CUBT)

[AllinFun]

There have been tons of numbers tossed around here. This company has assembled an impressive team since taking over control in Feb. 2021. I would say Michaels has done a very good job since taking over. They have 3 avenues right now in the BIO Pharm world - brain cancer treatment, degenerative eye treatment, and rabies. With that being said, there are many catalysts to come. The current market cap is abysmal in reference to what this company has fundamentally. If they continue to progress in the 3 avenues referenced and get clinical trials going then the price will move in a big way very quickly. This also assumes they receive financing which has been mentioned and sounds like it might already be in order.

With the share structure here, you could basically see $10+ easily in the next couple of years if things really progress. Of course that assumes there are no substantial dilutive measures taken to raise capital. In the short term they really need to get this N&S done to stop the bleeding in the short term (which is out of their hands entirely at this point as everything required has been submitted). Short term I could see $1-2 depending on the news released after the N&S change.